| Trifluridine–tipiracil and bevacizumab in refractory metastatic colorectal cancer GW Prager, J Taieb, M Fakih, F Ciardiello, E Van Cutsem, E Elez, ... New England Journal of Medicine 388 (18), 1657-1667, 2023 | 96 | 2023 |
| Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a … SB Winther, G Liposits, H Skuladottir, E Hofsli, CH Shah, LØ Poulsen, ... The lancet Gastroenterology & hepatology 4 (5), 376-388, 2019 | 59 | 2019 |
| Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review … NML Battisti, N De Glas, MS Sedrak, KP Loh, G Liposits, ... Therapeutic Advances in Medical Oncology 10, 1758835918809610, 2018 | 50 | 2018 |
| Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study. J Tabernero, GW Prager, M Fakih, F Ciardiello, E Van Cutsem, E Elez, ... Journal of Clinical Oncology 41 (4_suppl), 4-4, 2023 | 42 | 2023 |
| Perspectives on functional status in older adults with cancer: an interprofessional report from the International Society of Geriatric Oncology (SIOG) nursing and allied health … G Nightingale, NML Battisti, KP Loh, M Puts, C Kenis, A Goldberg, ... Journal of geriatric oncology 12 (4), 658-665, 2021 | 41 | 2021 |
| Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 … DEW van der Kruijssen, SG Elias, GR Vink, KL van Rooijen, L Mol, ... JAMA surgery, 2021 | 39 | 2021 |
| Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective I Desideri, S Pilleron, NML Battisti, F Gomes, N De Glas, NR Neuendorff, ... Journal of Geriatric Oncology 11 (7), 1175-1181, 2020 | 39 | 2020 |
| Nutrition in cancer care: a brief, practical guide with a focus on clinical practice G Liposits, Y Orrevall, S Kaasa, P Österlund, T Cederholm JCO Oncology Practice 17 (7), e992-e998, 2021 | 33 | 2021 |
| PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper G Liposits, KP Loh, E Soto-Perez-de-Celis, L Dumas, NML Battisti, ... Journal of geriatric oncology 10 (2), 337-345, 2019 | 25 | 2019 |
| Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine-or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre … P Osterlund, S Kinos, P Pfeiffer, T Salminen, JJM Kwakman, JE Frödin, ... ESMO open 7 (3), 100427, 2022 | 21 | 2022 |
| Integrating functional MRI information into conventional 3D radiotherapy planning of CNS tumors. Is it worth it? Á Kovács, L Tóth, C Glavák, G Liposits, J Hadjiev, G Antal, M Emri, ... Journal of neuro-oncology 105, 629-637, 2011 | 19 | 2011 |
| Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive … T André, A Falcone, Y Shparyk, F Moiseenko, E Polo-Marques, T Csöszi, ... The Lancet Gastroenterology & Hepatology 8 (2), 133-144, 2023 | 18 | 2023 |
| Quality of life in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy—the randomized NORDIC9-study G Liposits, HR Eshøj, S Möller, SB Winther, H Skuladottir, J Ryg, E Hofsli, ... Cancers 13 (11), 2604, 2021 | 17 | 2021 |
| The evolution of geriatric oncology and geriatric assessment over the past decade D Outlaw, M Abdallah, LA Gil-Jr, S Giri, T Hsu, JL Krok-Schoen, G Liposits, ... Seminars in radiation oncology 32 (2), 98-108, 2022 | 9 | 2022 |
| VP11-2021: Trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab as first line treatment for patients with metastatic colorectal cancer (mCRC) ineligible for … T André, A Falcone, Y Shparyk, FV Moiseenko, EP Marques, T Csoszi, ... Annals of Oncology 33 (2), 229-230, 2022 | 8 | 2022 |
| Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology SP Arora, G Liposits, S Caird, RF Dunne, GT Moffat, D Okonji, ... Journal of geriatric oncology 11 (4), 557-565, 2020 | 8 | 2020 |
| The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6) in vulnerable older patients with metastatic colorectal … G Liposits, H Skuladottir, J Ryg, SB Winther, S Möller, E Hofsli, CH Shah, ... Journal of clinical medicine 11 (19), 5603, 2022 | 7 | 2022 |
| Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer ML Rasmussen, G Liposits, S Yogendram, AB Jensen, S Linnet, ... Acta Oncologica 53 (9), 1275-1277, 2014 | 7 | 2014 |
| Conkiss: conformal kidneys sparing 3D noncoplanar radiotherapy treatment for pancreatic cancer as an alternative to IMRT Z Sebestyén, P Kovács, Á Gulybán, R Farkas, S Bellyei, G Liposits, ... Medical Dosimetry 36 (1), 35-40, 2011 | 7 | 2011 |
| Geriatric screening in older adults with cancer–A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative C Uranga, LC Chien, G Liposits Journal of Geriatric Oncology 13 (3), 374-377, 2022 | 6 | 2022 |
Nicolò Matteo Luca BattistiThe Royal Marsden NHS Foundation TrustVerified email at rmh.nhs.uk
